Variant report

Variant	nsv879224
Chromosome Location	chr4:69241928-69382080
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1090)
CpG islands
(count:366)
Chromatin interactive
region (count:30)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1090 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69364158-69364549	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69241724-69242046	HepG2	liver:	n/a	n/a
3	ATF2	chr4:69272567-69273233	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF2	chr4:69269806-69270384	H1-hESC	embryonic stem cell:	n/a	n/a
5	ATF2	chr4:69271370-69272360	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF2	chr4:69275508-69277104	H1-hESC	embryonic stem cell:	n/a	n/a
7	ATF2	chr4:69269850-69270608	H1-hESC	embryonic stem cell:	n/a	n/a
8	ATF2	chr4:69271320-69273979	H1-hESC	embryonic stem cell:	n/a	n/a
9	ATF2	chr4:69274062-69274402	H1-hESC	embryonic stem cell:	n/a	n/a
10	ATF2	chr4:69273374-69273928	H1-hESC	embryonic stem cell:	n/a	n/a
11	ATF2	chr4:69274713-69275097	H1-hESC	embryonic stem cell:	n/a	n/a
12	BACH1	chr4:69316907-69317183	H1-hESC	embryonic stem cell:	n/a	chr4:69317106-69317120
13	BACH1	chr4:69318318-69318341	H1-hESC	embryonic stem cell:	n/a	n/a
14	BATF	chr4:69364212-69364472	GM12878	blood:	n/a	n/a
15	BCL11A	chr4:69273602-69273847	H1-hESC	embryonic stem cell:	n/a	n/a
16	BCL11A	chr4:69275877-69276040	H1-hESC	embryonic stem cell:	n/a	n/a
17	BHLHE40	chr4:69364150-69364589	GM12878	blood:	n/a	n/a
18	BHLHE40	chr4:69241744-69242010	GM12878	blood:	n/a	n/a
19	BHLHE40	chr4:69305163-69305286	GM12878	blood:	n/a	n/a
20	BHLHE40	chr4:69241718-69241986	HepG2	liver:	n/a	n/a
21	BHLHE40	chr4:69241727-69241977	K562	blood:	n/a	n/a
22	BHLHE40	chr4:69249117-69249120	K562	blood:	n/a	n/a
23	BHLHE40	chr4:69250331-69250703	K562	blood:	n/a	n/a
24	BRCA1	chr4:69272255-69272927	H1-hESC	embryonic stem cell:	n/a	n/a
25	CBX3	chr4:69241617-69242163	HCT-116	colon:	n/a	n/a
26	CCNT2	chr4:69328625-69328750	K562	blood:	n/a	n/a
27	CEBPB	chr4:69278558-69278870	K562	blood:	n/a	n/a
28	CEBPB	chr4:69327525-69327817	MCF-7	breast:	n/a	n/a
29	CEBPB	chr4:69279178-69279415	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr4:69300021-69300356	K562	blood:	n/a	chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300188-69300199 chr4:69300190-69300199 chr4:69300190-69300201 chr4:69300190-69300199 chr4:69300188-69300201
31	CEBPB	chr4:69273497-69273975	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr4:69300096-69300253	H1-hESC	embryonic stem cell:	n/a	chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300188-69300199 chr4:69300190-69300199 chr4:69300190-69300201 chr4:69300190-69300199 chr4:69300188-69300201
33	CEBPB	chr4:69245383-69245660	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr4:69300033-69300365	HepG2	liver:	n/a	chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300188-69300199 chr4:69300190-69300199 chr4:69300190-69300201 chr4:69300190-69300199 chr4:69300188-69300201
35	CEBPB	chr4:69271428-69272246	H1-hESC	embryonic stem cell:	n/a	n/a
36	CEBPB	chr4:69248884-69249141	HepG2	liver:	n/a	n/a
37	CEBPB	chr4:69279172-69279414	K562	blood:	n/a	n/a
38	CEBPB	chr4:69310875-69311174	IMR90	lung:	n/a	chr4:69310996-69311009 chr4:69310996-69311009 chr4:69310996-69311007
39	CEBPB	chr4:69325378-69325503	K562	blood:	n/a	n/a
40	CEBPB	chr4:69300055-69300288	A549	lung:	n/a	chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300190-69300199 chr4:69300188-69300201 chr4:69300188-69300199 chr4:69300190-69300199 chr4:69300190-69300201 chr4:69300190-69300199 chr4:69300188-69300201
41	CEBPB	chr4:69321712-69322175	MCF-7	breast:	n/a	n/a
42	CEBPB	chr4:69321591-69322194	MCF-7	breast:	n/a	n/a
43	CEBPB	chr4:69312976-69313282	MCF-7	breast:	n/a	n/a
44	CEBPB	chr4:69241767-69242052	A549	lung:	n/a	n/a
45	CEBPB	chr4:69277211-69277380	Hela-S3	cervix:	n/a	n/a
46	CEBPB	chr4:69278653-69278888	HepG2	liver:	n/a	n/a
47	CEBPB	chr4:69308568-69308582	HepG2	liver:	n/a	n/a
48	CEBPB	chr4:69241684-69242049	Hela-S3	cervix:	n/a	n/a
49	CEBPB	chr4:69279166-69279328	K562	blood:	n/a	n/a
50	CEBPB	chr4:69279112-69279415	K562	blood:	n/a	n/a

(count:366 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69312104-69312154	GM19239	blood:	n/a
2	chr4:69355121-69355171	ProgFib	skin:	n/a
3	chr4:69340916-69340966	ovcar-3	ovarian:	n/a
4	chr4:69340916-69340966	HL-60	blood:	n/a
5	chr4:69313197-69313247	GM12891	blood:	n/a
6	chr4:69312514-69312564	ovcar-3	ovarian:	n/a
7	chr4:69355121-69355171	NHBE	bronchial:	n/a
8	chr4:69381368-69381418	HCM	heart:	n/a
9	chr4:69313197-69313247	NH-A	brain:	n/a
10	chr4:69355121-69355171	GM12892	blood:	n/a
11	chr4:69312514-69312564	ProgFib	skin:	n/a
12	chr4:69313197-69313247	ProgFib	skin:	n/a
13	chr4:69312104-69312154	HEEpiC	esophagus:	n/a
14	chr4:69313197-69313247	Caco-2	colon:	n/a
15	chr4:69355121-69355171	H1-hESC	embryonic stem cell:	embryo
16	chr4:69340916-69340966	AoSMC	blood vessel:	n/a
17	chr4:69381368-69381418	PrEC	prostate:	n/a
18	chr4:69381368-69381418	PFSK-1	brain:	n/a
19	chr4:69381368-69381418	HEEpiC	esophagus:	n/a
20	chr4:69355121-69355171	HPAEpiC	pulmonary alveolar:	n/a
21	chr4:69381368-69381418	U87	brain:	n/a
22	chr4:69355121-69355171	SK-N-SH	brain:	n/a
23	chr4:69312104-69312154	BE2_C	brain:	n/a
24	chr4:69312514-69312564	AG04449	skin:	fetal
25	chr4:69381368-69381418	MCF10A-Er-Src	breast:	n/a
26	chr4:69340916-69340966	HCPEpiC	choroid plexus:	n/a
27	chr4:69355121-69355171	RPTEC	kidney:	n/a
28	chr4:69312104-69312154	LNCaP	prostate:	n/a
29	chr4:69312514-69312564	Hepatocyte	liver:	n/a
30	chr4:69381368-69381418	NT2-D1	testis:	n/a
31	chr4:69313197-69313247	T-47D	breast:	n/a
32	chr4:69312104-69312154	HCPEpiC	choroid plexus:	n/a
33	chr4:69313197-69313247	Hepatocyte	liver:	n/a
34	chr4:69355121-69355171	SKMC	muscle:	n/a
35	chr4:69312104-69312154	AG09319	gingival:	n/a
36	chr4:69355121-69355171	AG10803	skin:	n/a
37	chr4:69381368-69381418	HepG2	liver:	n/a
38	chr4:69381368-69381418	MCF-7	breast:	n/a
39	chr4:69355121-69355171	GM06990	blood:	n/a
40	chr4:69340916-69340966	SK-N-MC	brain:	n/a
41	chr4:69313197-69313247	HIPEpiC	eye:	n/a
42	chr4:69355121-69355171	IMR90	lung:	fetal
43	chr4:69340916-69340966	NT2-D1	testis:	n/a
44	chr4:69312104-69312154	NT2-D1	testis:	n/a
45	chr4:69340916-69340966	HRCEpiC	kidney:	n/a
46	chr4:69381368-69381418	HCF	heart:	n/a
47	chr4:69355121-69355171	HRE	kidney:	n/a
48	chr4:69340916-69340966	SAEC	small airway:	n/a
49	chr4:69340916-69340966	HAEpiC	amniotic membrane:	n/a
50	chr4:69381368-69381418	K562	blood:	n/a

(count:30 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:69213603..69215709-chr4:69245624..69247287,2	K562	blood:
2	chr4:69317417..69319881-chr4:69327468..69329389,2	MCF-7	breast:
3	chr4:69235222..69236888-chr4:69330787..69333108,2	MCF-7	breast:
4	chr4:69314066..69315762-chr4:69317720..69319307,2	K562	blood:
5	chr4:69326187..69328959-chr4:69331153..69333884,3	MCF-7	breast:
6	chr4:69375140..69375898-chr4:69492301..69492816,2	MCF-7	breast:
7	chr4:69313083..69315969-chr4:69334821..69336429,2	MCF-7	breast:
8	chr4:69330018..69331837-chr4:69335427..69337976,2	MCF-7	breast:
9	chr4:69243264..69245251-chr4:69248916..69251183,2	K562	blood:
10	chr4:69261479..69263949-chr4:69265088..69267687,3	K562	blood:
11	chr4:69211043..69213753-chr4:69341284..69343236,2	K562	blood:
12	chr4:68794156..68795825-chr4:69317354..69319516,2	MCF-7	breast:
13	chr4:69330018..69331837-chr4:69335427..69337976,2	MCF-7	breast:
14	chr4:69314066..69315762-chr4:69317720..69319307,2	K562	blood:
15	chr4:69212970..69215845-chr4:69239349..69242311,2	MCF-7	breast:
16	chr4:69293251..69295177-chr4:69318009..69319544,2	K562	blood:
17	chr4:69308561..69313812-chr4:69314832..69320961,6	K562	blood:
18	chr4:69293251..69295177-chr4:69318009..69319544,2	K562	blood:
19	chr4:69215315..69216150-chr4:69241399..69242116,2	MCF-7	breast:
20	chr4:69243264..69245251-chr4:69248916..69251183,2	K562	blood:
21	chr4:69311298..69314792-chr4:69316366..69319525,5	MCF-7	breast:
22	chr4:69362843..69365661-chr4:69770776..69774163,4	MCF-7	breast:
23	chr4:69214168..69215842-chr4:69249504..69252039,2	MCF-7	breast:
24	chr4:69261479..69263949-chr4:69265088..69267687,3	K562	blood:
25	chr4:69363348..69364328-chr4:69890914..69891634,2	MCF-7	breast:
26	chr4:69215797..69217317-chr4:69361139..69363891,2	MCF-7	breast:
27	chr4:69143211..69145096-chr4:69239415..69241951,2	K562	blood:
28	chr4:69319066..69321050-chr4:69325892..69327547,2	MCF-7	breast:
29	chr4:68794694..68797024-chr4:69366841..69368465,2	MCF-7	breast:
30	chr4:69177090..69179857-chr4:69251602..69253290,2	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT2B17-1	chr4:69375159-69375392	NONHSAT096733

No data

Variant related genes	Relation type
TMPRSS11E	TF binding region
MT2P1	TF binding region
TMPRSS11E	CpG island
MT2P1	CpG island
ENSG00000087128	chromatin interactions
ENSG00000272626	chromatin interactions
ENSG00000249985	chromatin interactions
ENSG00000083896	chromatin interactions

Extended variants
information (count: 5164 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:5164 , 50 per page) page: 1 2 3 4 5 6 7 ... 104

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111571179	chr4:69241928-69241929	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs3797008	chr4:69241941-69241942	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs187271554	chr4:69241993-69241994	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs142525998	chr4:69242000-69242001	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs528998391	chr4:69242014-69242015	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs557031254	chr4:69242038-69242039	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs577298233	chr4:69242052-69242053	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs192108596	chr4:69242061-69242062	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs546263989	chr4:69242062-69242063	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs147637820	chr4:69242075-69242076	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs528615119	chr4:69242082-69242083	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs11549677	chr4:69242102-69242103	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs541633048	chr4:69242106-69242107	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs376262138	chr4:69242120-69242121	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs369220972	chr4:69242121-69242122	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs530677137	chr4:69242145-69242146	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs550844024	chr4:69242191-69242192	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs182657517	chr4:69242199-69242200	Active TSS Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs368804611	chr4:69242209-69242210	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs546222869	chr4:69242217-69242218	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs566195979	chr4:69242307-69242308	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs535194982	chr4:69242312-69242313	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs554816748	chr4:69242351-69242352	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs35810847	chr4:69242367-69242368	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs376258866	chr4:69242368-69242369	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs372175422	chr4:69242372-69242373	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs374821983	chr4:69242374-69242375	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs71218950	chr4:69242383-69242384	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs537285620	chr4:69242477-69242478	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs557627779	chr4:69242506-69242507	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs373981034	chr4:69242552-69242553	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs375534853	chr4:69242558-69242559	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs142313061	chr4:69242566-69242567	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs546188330	chr4:69242581-69242582	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs377662263	chr4:69242634-69242635	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs187610025	chr4:69242674-69242675	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs542320662	chr4:69242678-69242679	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs556760451	chr4:69242688-69242689	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs190005707	chr4:69242705-69242706	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs182585480	chr4:69242709-69242710	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs544103788	chr4:69242719-69242720	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs372772283	chr4:69242857-69242858	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs377286758	chr4:69242894-69242895	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs34500620	chr4:69242932-69242933	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs533071819	chr4:69242940-69242941	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs374021200	chr4:69242975-69242976	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs140311310	chr4:69243071-69243072	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs559720055	chr4:69243079-69243080	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs150421593	chr4:69243128-69243129	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs549051058	chr4:69243195-69243196	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Oral cancer	21386901	CNVD
Alcoholism	21790672	CNVD
small cell lung cancer	20016488	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Schizophrenia	20967226	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	22297974	CNVD

Chromatin state (count:766 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69232200-69255600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr4:69234200-69242000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr4:69235200-69242000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
4	chr4:69235800-69243000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr4:69237400-69242000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr4:69239400-69242000	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
7	chr4:69239600-69242000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
8	chr4:69239600-69242000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
9	chr4:69239600-69242000	Weak transcription	Primary monocytes fromperipheralblood	blood
10	chr4:69239600-69242000	Weak transcription	Brain Substantia Nigra	brain
11	chr4:69239600-69242000	Weak transcription	Colonic Mucosa	Colon
12	chr4:69239600-69242000	Weak transcription	Psoas Muscle	Psoas
13	chr4:69240000-69245000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
14	chr4:69241400-69242000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
15	chr4:69241400-69242200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr4:69241400-69242200	Bivalent/Poised TSS	Fetal Kidney	kidney
17	chr4:69241400-69242200	Bivalent Enhancer	Fetal Lung	lung
18	chr4:69241400-69242400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
19	chr4:69241600-69242000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
20	chr4:69241600-69242000	Enhancers	Primary T killer memory cells from peripheral blood	blood
21	chr4:69241600-69242200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
22	chr4:69241600-69242200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr4:69241600-69242200	Enhancers	Primary T helper naive cells from peripheral blood	blood
24	chr4:69241600-69242200	Enhancers	Stomach Mucosa	stomach
25	chr4:69241600-69242400	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
26	chr4:69241600-69242400	Active TSS	iPS-20b Cell Line	embryonic stem cell
27	chr4:69241600-69242400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
28	chr4:69241600-69242400	Enhancers	Liver	Liver
29	chr4:69241800-69242000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr4:69241800-69242000	Active TSS	Primary B cells from cord blood	blood
31	chr4:69241800-69242000	Active TSS	Primary T cells fromperipheralblood	blood
32	chr4:69241800-69242000	Active TSS	Primary hematopoietic stem cells short term culture	blood
33	chr4:69241800-69242000	Active TSS	Primary T helper naive cells fromperipheralblood	blood
34	chr4:69241800-69242000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
35	chr4:69241800-69242000	Active TSS	Primary T helper cells fromperipheralblood	blood
36	chr4:69241800-69242000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
37	chr4:69241800-69242000	Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr4:69241800-69242000	Active TSS	Muscle Satellite Cultured Cells	--
39	chr4:69241800-69242000	Active TSS	Cortex derived primary cultured neurospheres	brain
40	chr4:69241800-69242000	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
41	chr4:69241800-69242000	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr4:69241800-69242000	Flanking Active TSS	Brain Anterior Caudate	brain
43	chr4:69241800-69242000	Active TSS	Brain Hippocampus Middle	brain
44	chr4:69241800-69242000	Enhancers	Brain Inferior Temporal Lobe	brain
45	chr4:69241800-69242000	Active TSS	Duodenum Mucosa	Duodenum
46	chr4:69241800-69242000	Active TSS	Esophagus	oesophagus
47	chr4:69241800-69242000	Active TSS	Rectal Mucosa Donor 29	rectum
48	chr4:69241800-69242000	Active TSS	Rectal Smooth Muscle	rectum
49	chr4:69241800-69242000	Active TSS	Skeletal Muscle Female	skeletal muscle
50	chr4:69241800-69242000	Active TSS	HMEC	breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links